REGN6569
R6569-ONC-1933
Phase 1 small_molecule terminated
Quick answer
REGN6569 for Squamous Cell Carcinoma of Head and Neck is a Phase 1 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Squamous Cell Carcinoma of Head and Neck
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated